Success Stories

Erbitux ®

An antibody based therapy presenting synergism with conventional chemotherapy. The synergistic effect was invented at the Weizmann Institute. Erbitux was developed by ImClone Systems and approved by the FDA in 2001. Imclone has a license to the synergism patent. Erbitux Sales in 2007 exceeded 1B$ (Yeda).

EXELON

Exelon is a cholinesterase inhibitor, a type of medicine prescribed for people in the early or middle stages of Alzheimer's disease. Though not a cure, Exelon has been shown to be an effective medicine for treating the symptoms of mild to moderate Alzheimer's disease.
Exelon provides hope for people with Alzheimer's disease and the people who care for them. It can slow the progression of symptoms and help people with mild to moderate Alzheimer's disease stay connected longer to the relationships and activities they value and enjoy.

Product developed by; Marta Weinstock-Rosin, Department of Pharmacology, Hebrew University (Yissum)

InterPharm Laboratories Ltd.

InterPharm Laboratories Ltd., founded in 1978 and today a subsidiary of Merck-Serono, was for many years the largest biotechnology company in Israel, developed recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases. All the products developed at InterPharm Laboratories (Interferon b, Interleukin-6 and soluble TNF receptors) emanated from Institute research. One product, Rebif®, is being commercially marketed (Yeda)

MobilEye Vision Technologies Ltd.

MobilEye was incorporated for the purpose of developing and marketing advanced products in the surging market of automated on-board driver assistant systems. The company has developed a number of proprietary algorithms and reference platforms that need only a single video camera for ACC, lane departure warning and collision mitigation. Multiple cameras are not needed for depth of scene calculation because MobilEye`s algorithms use an advanced spatio-temporal classification technique based on a novel machine learning approach that trains the system with static and dynamic visual information. (Yissum)
http://www.mobileye.com/

NDS Ltd

NDS Ltd. established in 1985, developing smart cards to prevent unauthorized access to computer data and satellite television broadcasts. The technology is based on an algorithm developed in the Institute's Faculty of Mathematics and Computer Sciences. NDS is traded on Nasdaq (NNDS) (Yeda)
http://www.nds.com/